Low Dose Lipopolysaccharide-Induced Depressive-Like Phenotype is Mediated by Proinflammatory Cytokines in Mice and Role of Ketamine

被引:0
|
作者
Praharaj, Shuvranshu [1 ,3 ]
Kalaichelvan, Vandurayanpet Kaliyamoorthy [1 ]
Murugan, Vedigounder [2 ]
Venkatachalam, Velappan [1 ]
Ahmad, Ishtiyaque [3 ]
机构
[1] Annamalai Univ, Dept Pharm, Chidambaram 608002, Tamil Nadu, India
[2] Dayananda Sagar Univ, Coll Pharmaceut Sci, Dept Pharm, Bangalore, Karnataka, India
[3] Jubilant Biosys Ltd, Dept Biol, Bangalore, Karnataka, India
关键词
B/P; Cytokines; Depression; LPS; FST; SPT; DEXAMETHASONE; LPS;
D O I
10.5530/ijper.58.3s.79
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Background: Depression is a common mental illness, with an estimated 3.8% of global population affected. In the pathophysiology of depression, ketamine acts quickly in patients. Treatment with low-dose ketamine upon administration to stressed C57BL/6J mice is now a major translational research area to facilitate further innovation. Objectives: The present work was aimed to establish a depressant like animal model after 6 days of LPS injection, where LPS did not promote body weight loss. Materials and Methods: Peripheral administration of low dose of Lipopolysaccharide (LPS) activates cytokines and culminate in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in the forced swim and anhedonia in sucrose preference tests. Cytokines like TNF-alpha, IL-6, IL-1 beta and IFN-gamma were determined in brain homogenate and in plasma using western blot performed with automated Jess system (ProteinSimple) and ELISA respectively. Results: Ketamine prevents development of depressive-like behavior by decreasing swimming behavior and increasing preference to sucrose in stressed animals. Ketamine treatment reduced the LPS induced secretion of IFN-gamma (p<0.05 for 30 mpk), IL-6 (p<0.05 for 30 mpk), TNF-alpha (p<0.0001 for 30 mpk) and IL-1 beta in plasma. Similarly, ketamine treatment reduced the LPS induced secretion of IFN-gamma (p<0.001 for 10 and 30 mpk), IL-6, TNF-alpha (p<0.01 for 10 and 30 mpk) and IL-1 beta (p<0.05 for 10 mpk, p<0.0001 for 30 mpk) in brain. The plasma and brain concentrations of ketamine were analysed using LC-MS/MS and Brain/ Plasma ratio (B/P) of ketamine at 10 and 30 mpk were calculated as 0.70 and 0.82 respectively. Conclusion: In summary, these data emphasizes that ketamine treatment modulate cytokine level, showed good brain to plasma exposure and provides its anti-stress effects in the C57BL/6 mouse strain, which may be possible reason for the anti-depression property and is relevant to human stress-induced depression.
引用
收藏
页码:s777 / s786
页数:10
相关论文
共 50 条
  • [21] NMDA receptor activation mediates lipopolysaccharide-induced depressive-like behavior
    Walker, Adam
    Smith, Robin
    Beenders, Bret
    Kelley, Keith
    Dantzer, Robert
    EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY, 2012, 3
  • [22] Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis
    Liu, Liang
    Zhang, Qin
    Cai, Yulong
    Sun, Dayu
    He, Xie
    Wang, Lian
    Yu, Dan
    Li, Xin
    Xiong, Xiaoyi
    Xu, Haiwei
    Yang, Qingwu
    Fan, Xiaotang
    ONCOTARGET, 2016, 7 (35) : 56045 - 56059
  • [23] NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
    Walker, Adam K.
    Budac, David P.
    Bisulco, Stephanie
    Lee, Anna W.
    Smith, Robin A.
    Beenders, Brent
    Kelley, Keith W.
    Dantzer, Robert
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (09) : 1609 - 1616
  • [24] Targeting PERK mediated endoplasmic reticulum stress attenuates neuroinflammation and alleviates lipopolysaccharide-induced depressive-like behavior in male mice
    Xu, Xiao Fan
    Shi, Meng Meng
    Luo, Ming Ying
    Liu, Dan Dan
    Guo, Dong Ming
    Chen, Ling
    Zhong, Xiao Lin
    Xu, Yang
    Cao, Wen Yu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111
  • [25] NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
    Adam K Walker
    David P Budac
    Stephanie Bisulco
    Anna W Lee
    Robin A Smith
    Brent Beenders
    Keith W Kelley
    Robert Dantzer
    Neuropsychopharmacology, 2013, 38 : 1609 - 1616
  • [26] Diene Valepotriates from Valeriana glechomifolia Prevent Lipopolysaccharide-Induced Sickness and Depressive-Like Behavior in Mice
    Mueller, Liz G.
    Borsoi, Milene
    Stolz, Eveline D.
    Herzfeldt, Vivian
    Viana, Alice F.
    Ravazzolo, Ana Paula
    Rates, Stela Maris K.
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [27] Selanylimidazopyridine Prevents Lipopolysaccharide-Induced Depressive-Like Behavior in Mice by Targeting Neurotrophins and Inflammatory/Oxidative Mediators
    Domingues, Micaela
    Casaril, Angela M.
    Birmann, Paloma T.
    Lourenco, Darling de A.
    Vieira, Beatriz
    Begnini, Karine
    Lenardao, Eder J.
    Collares, Tiago
    Seixas, Fabiana K.
    Savegnago, Lucielli
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [28] Atractylodin ameliorates lipopolysaccharide-induced depressive-like behaviors in mice through reducing neuroinflammation and neuronal damage
    Liu, Feng
    Wang, Yaping
    Li, Dongbo
    Yang, Tao
    JOURNAL OF NEUROIMMUNOLOGY, 2024, 390
  • [29] Gentiopicroside abrogates lipopolysaccharide-induced depressive-like behavior in mice through tryptophan-degrading pathway
    Ya-ting Deng
    Ming-gao Zhao
    Tian-jiao Xu
    Xin-hua Jin-Hou
    Metabolic Brain Disease, 2018, 33 : 1413 - 1420
  • [30] Resveratrol abrogates lipopolysaccharide-induced depressive-like behavior, neuroinflammatory response, and CREB/BDNF signaling in mice
    Ge, Li
    Liu, Liwei
    Liu, Hansen
    Liu, Song
    Xue, Hao
    Wang, Xueer
    Yuan, Lin
    Wang, Zhen
    Liu, Dexiang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 768 : 49 - 57